The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical efficacy and safety of regorafenib (REG) in the treatment of metastatic colorectal cancer (mCRC) in daily practice in Germany: Interim results of the prospective multicentre noninterventional RECORA study.
 
Holger Schulz
No Relationships to Disclose
 
Jan Janssen
Honoraria - Amgen/Onyx; Baxter; Bayer; Biotest; Bristol-Myers Squibb; Celgene; Janssen-Cilag; Kedrion Biopharma; Lilly/ImClone; Merck Serono; Novartis; Octapharm; Pfizer; Puma Biotechnology; Roche; Sanofi; Teva
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Novartis; Roche; Sanofi
 
Uwe P. Strauss
Employment - Bayer
 
Markus Langen
Employment - Bayer
 
Marcel Frey
No Relationships to Disclose
 
Sabine Fiala-Buskies
Employment - Bayer
Stock and Other Ownership Interests - Bayer
 
Carsten Bokemeyer
Honoraria - Bayer; Bristol-Myers Squibb; Merck KGaA; Roche; Sanofi
Consulting or Advisory Role - Bayer Schering Pharma; Hexal; Lilly/ImClone; Merck Serono; Mundipharma; Sanofi
Travel, Accommodations, Expenses - Merck Serono; Sanofi